BEVERLY HILLS, Calif., July 25, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ),
a global decontamination company that specializes in disinfection/decontamination sales and services, including
SteraMist™, a hydrogen peroxide-based mist/fog registered with the U.S. Environmental Protection Agency (“EPA”) for use
as a hospital-healthcare disinfectant, is pleased to announce its addition of three new partners as it continues its growth into
international markets – Chile (Bacteria Free SpA), Brazil (AG3 Solutions) and Portugal (Type Solutions). These three companies have
been added to the list of TOMI’s international partners. The Director of AG3 Solutions recently shared, “We’ve been working as a
services and solutions providers for pharmaceutical industries in Brazil for more than 10 years and our customers are always
expecting us to provide the most innovative and efficient solutions for their daily challenges. We are confident the
SteraMist™ system will be an effective tool in addressing our client needs and creating a safer environment.”
This 2nd quarter expansion into these select countries is an exciting growth opportunity to bring the TOMI patented
disinfection/decontamination technology to the healthcare and life science industries in each country. Additionally, our
representation in Brazil and Portugal will also include the food safety industry.
Dr. Shane, TOMI’s CEO, welcomes the new representatives, “These partnerships that we continue to develop overseas are critical
as the threat of emerging pathogens and disease contamination is worldwide and not restricted to the United States alone. We look
forward to working with our new partners and are committed to providing them the resources necessary to make a significant and
positive impact in their territories.” TOMI is committed to developing future partnerships around the world in an effort to expand
its global reach.
About TOMI Environmental Solutions, Inc.
TOMI Environmental Solutions, Inc. (OTCQX:TOMZ) is a global decontamination and infection prevention company, providing
environmental solutions for indoor surface disinfection through manufacturing, sales and licensing of its premier Binary Ionization
Technology® (BIT™) platform, which was invented under a defense grant in association with the Defense Advanced Research Projects
Agency (DARPA) of the U.S. Department of Defense. BIT™ uses a low percentage Hydrogen Peroxide as its only active ingredient to
produce a hydroxyl radical (OH ion), represented by the TOMI™ SteraMist™ brand of products, which produces a germ-killing aerosol
that works like a visual non-caustic gas.
TOMI’s products are designed to service a broad spectrum of commercial structures including but not limited to
hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce
processing facilities (when not in operation), military barracks, police and fire departments, and athletic facilities. TOMI’s
products and services have also been used in single-family homes and multi-unit residences.
TOMI also develops training programs and application protocols for its clients and is a member in good standing
of The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection
Control and Epidemiology, Society for Healthcare Epidemiology of America and The Restoration Industry Association.
For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the
Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and
phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,”
“projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases.
All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future,
including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking
statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk
factors that could cause our actual results to differ materially from our anticipated results. The information provided in this
document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking
statements after the date of this release
MEDIA RELATIONS CONTACT Juliana deRosa Executive Administrator jderosa@tomimist.com
![Primary Logo](https://resource.globenewswire.com/Resource/Download/6b3f2fdf-3258-4c41-8983-fe11e94441bc?size=1)
![](http://www.globenewswire.com/newsroom/ti?ndecode=NzA2MzkjNjkxODIxNA==)